메뉴 건너뛰기




Volumn 35, Issue 3, 2014, Pages 1867-1873

Variability of assay methods for total and free PSA after WHO standardization

Author keywords

free PSA; Prostate cancer; PSA; WHO PSA standards

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 84898845089     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1249-2     Document Type: Article
Times cited : (25)

References (21)
  • 1
    • 41149166182 scopus 로고    scopus 로고
    • Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring
    • 18337732 10.1038/nrc2351
    • Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer. 2008;8:268-78.
    • (2008) Nat Rev Cancer , vol.8 , pp. 268-278
    • Lilja, H.1    Ulmert, D.2    Vickers, A.J.3
  • 2
    • 78649362120 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease
    • 21056534 10.1016/j.eururo.2010.10.039
    • Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59:61-71.
    • (2011) Eur Urol , vol.59 , pp. 61-71
    • Heidenreich, A.1    Bellmunt, J.2    Bolla, M.3
  • 3
    • 23944492852 scopus 로고    scopus 로고
    • Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: Systematic review and meta-analysis
    • 15982797 10.1016/j.eururo.2005.04.015
    • Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol. 2005;48:386-99.
    • (2005) Eur Urol , vol.48 , pp. 386-399
    • Roddam, A.W.1    Duffy, M.J.2    Hamdy, F.C.3
  • 4
    • 33646009994 scopus 로고    scopus 로고
    • A meta-analysis of the performance characteristics of the free prostate-specific antigen test
    • Free PSA Study Group et al. 16600352 10.1016/j.urology.2005.10.052
    • Lee R, Localio AR, Armstrong K, Free PSA Study Group, et al. A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Urology. 2006;67:762-8.
    • (2006) Urology , vol.67 , pp. 762-768
    • Lee, R.1    Localio, A.R.2    Armstrong, K.3
  • 5
    • 0030339750 scopus 로고    scopus 로고
    • Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values
    • 8950358 10.1002/(SICI)1097-0045(1996)7+<3: AID-PROS1>3.0.CO;2-T
    • Semjonow A, Brandt B, Oberpenning F, Roth S, Hertle L. Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values. Prostate Suppl. 1996;7:3-16.
    • (1996) Prostate Suppl , vol.7 , pp. 3-16
    • Semjonow, A.1    Brandt, B.2    Oberpenning, F.3    Roth, S.4    Hertle, L.5
  • 6
    • 0029240414 scopus 로고
    • Second Stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994
    • 7531897 10.1016/0090-4295(95)80001-8
    • Stamey TA. Second Stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994. Urology. 1995;45:173-84.
    • (1995) Urology , vol.45 , pp. 173-184
    • Stamey, T.A.1
  • 7
    • 29744462375 scopus 로고    scopus 로고
    • Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: An update
    • 16391327 10.1373/clinchem.2005.059170
    • Stephan C, Klaas M, Muller C, Schnorr D, Loening SA, Jung K. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update. Clin Chem. 2006;52:59-64.
    • (2006) Clin Chem , vol.52 , pp. 59-64
    • Stephan, C.1    Klaas, M.2    Muller, C.3    Schnorr, D.4    Loening, S.A.5    Jung, K.6
  • 8
    • 33746633333 scopus 로고    scopus 로고
    • Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation
    • 16762996 10.1373/clinchem.2006.069039
    • Kort S, Martens F, Vanpoucke H, et al. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. Clin Chem. 2006;52:1568-74.
    • (2006) Clin Chem , vol.52 , pp. 1568-1574
    • Kort, S.1    Martens, F.2    Vanpoucke, H.3
  • 9
    • 45949106975 scopus 로고    scopus 로고
    • Intermethod differences in results for total PSA, free PSA, and percentage of free PSA
    • 18480013 10.1309/JYBPMFNUF6EYY9TB
    • Slev PR, La'ulu SL, Roberts WL. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA. Am J Clin Pathol. 2008;129:952-8.
    • (2008) Am J Clin Pathol , vol.129 , pp. 952-958
    • Slev, P.R.1    La'Ulu, S.L.2    Roberts, W.L.3
  • 10
    • 73349116583 scopus 로고    scopus 로고
    • Discordant total and free prostate-specific antigen (PSA) assays: Does calibration with WHO reference materials diminish the problem?
    • 19778292 10.1515/CCLM.2009.285
    • Stephan C, Köpke T, Semjonow A, et al. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem? Clin Chem Lab Med. 2009;47:1325-31.
    • (2009) Clin Chem Lab Med , vol.47 , pp. 1325-1331
    • Stephan, C.1    Köpke, T.2    Semjonow, A.3
  • 11
    • 84865335131 scopus 로고    scopus 로고
    • Standardization of assay methods reduces variability of total PSA measurements: An Irish study
    • 22897326 10.1111/j.1464-410X.2011.10923.x
    • Forde JC, Marignol L, Blake O, et al. Standardization of assay methods reduces variability of total PSA measurements: an Irish study. BJU Int. 2012;110:644-50.
    • (2012) BJU Int , vol.110 , pp. 644-650
    • Forde, J.C.1    Marignol, L.2    Blake, O.3
  • 12
    • 30844455114 scopus 로고    scopus 로고
    • Prostate-specific antigen: Bias and molarity of commercial assays for PSA in use in England
    • 16390608 10.1258/000456306775141731
    • Roddam AW, Rimmer J, Nickerson C, Ward AM. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England. Ann Clin Biochem. 2006;43(Pt 1):35-48.
    • (2006) Ann Clin Biochem , vol.43 , Issue.PART 1 , pp. 35-48
    • Roddam, A.W.1    Rimmer, J.2    Nickerson, C.3    Ward, A.M.4
  • 13
    • 2642574977 scopus 로고    scopus 로고
    • Assessing the clinical impact of prostate-specific antigen assay variability and nonequimolarity: A simulation study based on the population of the United Kingdom
    • 15031266 10.1373/clinchem.2004.031138
    • Roddam AW, Price CP, Allen NE, Ward AM. Assessing the clinical impact of prostate-specific antigen assay variability and nonequimolarity: a simulation study based on the population of the United Kingdom. Clin Chem. 2004;50:1012-6.
    • (2004) Clin Chem , vol.50 , pp. 1012-1016
    • Roddam, A.W.1    Price, C.P.2    Allen, N.E.3    Ward, A.M.4
  • 14
    • 70349757756 scopus 로고    scopus 로고
    • American Urological Association Accessed 26 Jan 2013
    • American Urological Association. Prostate-Specific Antigen Best Practice Statement: 2009 update. http://www.auanet.org/content/guidelines-andquality- care/clinical-guidelines/mainreports/psa09.pdf (2009). Accessed 26 Jan 2013.
    • (2009) Prostate-Specific Antigen Best Practice Statement: 2009 Update
  • 16
    • 0028073510 scopus 로고
    • Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves
    • 7525994
    • Catalona WJ, Richie JP, deKernion JB, et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol. 1994;152:2031-6.
    • (1994) J Urol , vol.152 , pp. 2031-2036
    • Catalona, W.J.1    Richie, J.P.2    Dekernion, J.B.3
  • 17
    • 63249122661 scopus 로고    scopus 로고
    • Mortality results from a randomized prostate-cancer screening trial
    • 2944770 19297565 10.1056/NEJMoa0810696
    • Andriole GL, Crawford ED, Grubb 3rd RL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-9.
    • (2009) N Engl J Med , vol.360 , pp. 1310-1319
    • Andriole, G.L.1    Crawford, E.D.2    Grubb III, R.L.3
  • 18
    • 63249118690 scopus 로고    scopus 로고
    • Screening and prostate-cancer mortality in a randomized European study
    • 19297566 10.1056/NEJMoa0810084
    • Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-8.
    • (2009) N Engl J Med , vol.360 , pp. 1320-1328
    • Schröder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 19
    • 57149088140 scopus 로고    scopus 로고
    • Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detection
    • 18927249 10.1373/clinchem.2007.102699
    • Jansen FH, Roobol M, Bangma CH, van Schaik RH. Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detection. Clin Chem. 2008;54:1999-2006.
    • (2008) Clin Chem , vol.54 , pp. 1999-2006
    • Jansen, F.H.1    Roobol, M.2    Bangma, C.H.3    Van Schaik, R.H.4
  • 20
    • 33846002787 scopus 로고    scopus 로고
    • Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes
    • 17222629 10.1016/j.juro.2006.10.097
    • Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007;177:540-5.
    • (2007) J Urol , vol.177 , pp. 540-545
    • Cookson, M.S.1    Aus, G.2    Burnett, A.L.3
  • 21
    • 77649195776 scopus 로고    scopus 로고
    • WHO standarization of PSA tests: Clinical consequences
    • 19498407 10.1038/nrurol.2009.94
    • Stephan C. WHO standarization of PSA tests: clinical consequences. Nat Rev Urol. 2009;6:303-5.
    • (2009) Nat Rev Urol , vol.6 , pp. 303-305
    • Stephan, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.